Adrenapar

Adrenapar is an FDA drug label for the active ingredient ARALIA QUINQUEFOLIA, AVENA SATIVA, GLANDULA SUPRARENALIS SUIS, ARSENICUM IODATUM, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ZINCUM METALLICUM manufactured by Energique, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20220810.

Generic: ARALIA QUINQUEFOLIA, AVENA SATIVA, GLANDULA SUPRARENALIS SUIS, ARSENICUM IODATUM, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ZINCUM METALLICUM

Manufacturer: Energique, Inc.

Product Type: HUMAN OTC DRUG

Route: ORAL

Dosage Form:

NDC: 44911-0037

Application:

Effective: 20220810

Active Ingredients: ACTIVE INGREDIENTS: Aralia Quinquefolia 3X, Avena Sativa 3X, Glandula Suprarenalis Suis 6X, Arsenicum Iodatum 12X, Ignatia Amara 12X, Lycopodium Clavatum 12X, Nux Vomica 12X, Phosphoricum Acidum 12X, Phosphorus 12X, Zincum Metallicum 12X.

Indications & Usage

INDICATIONS: May temporarily relieve nervous exhaustion, fatigue and forgetfulness.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Dosage & Administration

DIRECTIONS: Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist, consult your health care professional. Consult a physician for use in children under 12 years of age.

Contraindications

Not available.

Warnings

WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.

Adverse Reactions